Supriya Lifescience Ltd. (SUPRIYA): Supriya Lifescience Share Price Rises 5.69% to Rs 957
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Supriya Lifescience Share Price moved to Rs 957 today, up 5.69% from the previous close of Rs 905.50, with market capitalisation at Rs 7,287.72 crore. The session also showed a high of Rs 957.20 and a low of Rs 907.70, while turnover stood at Rs 2.10 crore. The move confirms a same-day price rise, but the supplied data does not establish a company-specific catalyst. In Univest terms, this makes Supriya Lifescience Stock News relevant for investors tracking the day’s share price rise, valuation context and healthcare sector positioning. The first reading is simple: the stock is higher today, and the market is assessing that move alongside its current earnings profile, return ratios and peer comparison. For readers following Supriya Lifescience Share Price Today, the key next checks are whether the move is sustained, how it compares with the industry benchmark and whether fundamentals remain consistent with the current valuation.
Supriya Lifescience Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 957 |
| Previous Close | Rs 905.5 |
| Today's Move | Rs 51.5 (+5.69%) |
| Open | Rs 911.95 |
| High | Rs 957.2 |
| Low | Rs 907.7 |
| Turnover | Rs 2.1 crore |
| Market Capitalisation | Rs 7,287.72 crore |
| Market Cap Category | Mid Cap |
Supriya Lifescience Ltd. (SUPRIYA) rose to Rs 957 from the previous close of Rs 905.5, a move of Rs 51.5 or 5.69%. The stock opened at Rs 911.95, reached a high of Rs 957.2, recorded a low of Rs 907.7.
Supriya Lifescience Share Price Today reflects a clear one-day gain of Rs 51.50, or 5.69%, from Rs 905.50 to Rs 957. The stock opened at Rs 911.95, moved between Rs 907.70 and Rs 957.20, and finished close to the day’s high. That is the factual price action seen in Supriya Lifescience Share Price News today. The move places the stock among the day’s notable gainers within the context of Stocks in News, although the supplied data confirms the price event rather than any reason for it. For readers tracking Supriya Lifescience Share Price Live, the useful takeaway is that the day’s range stayed relatively tight around the upper end of the session, and the closing level remained above the open and previous close.
In Univest coverage, this kind of share price rise is best read as a verified market event first and a narrative second. The company’s day move, turnover of Rs 2.10 crore and market cap of Rs 7,287.72 crore together provide the basic price-event context for Supriya Lifescience Stock Performance today. The data confirms the rise; it does not identify a specific company news trigger. That is the correct lens for Supriya Lifescience Latest News and Supriya Lifescience Share Price Update watchers.
Supriya Lifescience Ltd. (SUPRIYA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 7,287.72 crore |
| P/E Ratio | 36.74x |
| P/B Ratio | 5.96x |
| ROE | 19.06% |
| ROCE | 25.3% |
| EPS | Rs 24.65 |
| Book Value Per Share | Rs 151.81 |
| Dividend Yield | 0.11% |
Supriya Lifescience Ltd. (SUPRIYA) fundamental metrics show P/E 36.74x, P/B 5.96x, ROE 19.06%, ROCE 25.3%. These figures provide context only and are not a buy or sell signal.
Supriya Lifescience Ltd. has a market capitalisation of Rs 7287.72 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 36.74x, P/B at 5.96x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.06% and ROCE of 25.3%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 24.65, book value per share of Rs 151.81, dividend yield of 0.11%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 36.74x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 48.77x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 5.96x |
| Benchmark Median P/B | 3.08x |
| Company ROE | 19.06% |
| Benchmark Median ROE | 11.7% |
| Company ROCE | 25.3% |
| Benchmark Median ROCE | 13.46% |
| Company Market Capitalisation | Rs 7,287.72 crore |
| Benchmark Median Market Cap | Rs 701.78 crore |
Supriya Lifescience Ltd. (SUPRIYA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Supriya Lifescience Ltd. (SUPRIYA) has a P/E ratio of 36.74x, which is above the benchmark median of 32.87x, a difference of +11.77%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Supriya Lifescience Ltd. (SUPRIYA) has a ROE of 19.06%, which is above the benchmark median of 11.7%, a difference of +62.91%. Supriya Lifescience Ltd. (SUPRIYA) has a ROCE of 25.3%, which is above the benchmark median of 13.46%, a difference of +87.96%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 36.41 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.01 | 14.08 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 83.79 | 20.36 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.48 | 4.27 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 32.87 | 3.15 | 11.83 | 16 |
Supriya Lifescience Ltd. (SUPRIYA) has a P/E ratio of 36.74x compared with the displayed peer median of 36.41x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.06% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 25.3% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Supriya Lifescience Ltd. (SUPRIYA) has a market capitalisation of Rs 7,287.72 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Supriya Lifescience
- Supriya Lifescience Share Price rose 5.69% today to Rs 957 from Rs 905.50.
- The stock closed near the day’s high of Rs 957.20 after opening at Rs 911.95.
- Market capitalisation stands at Rs 7,287.72 crore, which provides scale context for Supriya Lifescience Share Price Today.
- P/E of 36.74 and P/B of 5.96 place the stock above the same-industry median on both valuation measures.
- ROE of 19.06% and ROCE of 25.30% are above the same-industry medians, adding financial context to Supriya Lifescience Stock News.
About Supriya Lifescience
Supriya Lifescience Ltd. is part of the Healthcare sector and operates in Pharmaceuticals & Drugs. The supplied data does not provide a segment breakdown, so the company can be discussed only at the industry level here. That is still enough to place Supriya Lifescience Share Price in a broader operating context. Investors following Supriya Lifescience Stock News typically compare the company’s earnings, valuation and return ratios with other pharma names because the industry includes both large integrated manufacturers and more specialised players.
From the available figures, the company’s financial profile is defined by a market capitalisation of Rs 7,287.72 crore, EPS of Rs 24.65, book value of Rs 151.81 and a dividend yield of 0.11%. Those numbers make Supriya Lifescience Share Price more than a one-day move; they give a basis for comparison with the broader Pharmaceuticals & Drugs universe. In Univest research terms, the stock is best understood through company overview, financial ratios and sector positioning rather than through the day’s price alone.
Track Supriya Lifescience Share Price on Univest
Use Supriya Lifescience Ltd. (SUPRIYA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Univest users can track Supriya Lifescience Share Price Live, valuation ratios, shareholding pattern, sector context, 52-week levels and company updates on the dedicated stock page. The platform also helps readers compare Supriya Lifescience Stock Analysis with peer names across Healthcare and the wider Indian stock market. For those following Supriya Lifescience Share Price Today, this keeps the day’s share price rise connected to financial analysis and market update context in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Supriya Lifescience Share Price rising today?
Ans. Supriya Lifescience Share Price rose 5.69% to Rs 957 today. The supplied data confirms the price event, but it does not establish a company-specific catalyst, so the move should be read as verified price action.
What is Supriya Lifescience Share Price today?
Ans. Supriya Lifescience Share Price Today is Rs 957. It is up Rs 51.50 from the previous close of Rs 905.50, and the day’s range was Rs 907.70 to Rs 957.20.
What is Supriya Lifescience market capitalisation?
Ans. Supriya Lifescience Market Cap stands at Rs 7,287.72 crore. That places the company well above the same-industry median market capitalisation of Rs 701.78 crore in the supplied Healthcare benchmark set.
How does Supriya Lifescience valuation compare with peers?
Ans. Supriya Lifescience has a P/E of 36.74 and P/B of 5.96. That is above the same-industry medians of 32.87 and 3.08, while remaining below several higher-valued pharma peers. The company trades at a P/E ratio of 36.74x.
What do the profitability ratios show for Supriya Lifescience?
Ans. Supriya Lifescience reports ROE of 19.06% and ROCE of 25.30%. Both are above the same-industry medians, which adds useful context when reading the current Supriya Lifescience Share Price move. ROE stands at 19.06%.
What do EPS and book value mean for Supriya Lifescience?
Ans. EPS is Rs 24.65, showing earnings attributable to each share. Book value is Rs 151.81, showing accounting net worth per share. Both help frame Supriya Lifescience Share Price in financial terms.
Does Supriya Lifescience have a dividend yield?
Ans. Yes, the dividend yield is 0.11%. That is a factual yield measure based on the current price, and it should be read alongside earnings, book value and other company financials.
Which sector and industry does Supriya Lifescience belong to?
Ans. Supriya Lifescience belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. This sector context is important because valuation and profitability are best assessed against listed pharma peers. The stock belongs to the Healthcare sector.
